PAREXEL International to Present at Goldman Sach Global Healthcare Conference and Jefferies Healthcare Conference
BOSTON, May 24, 2016 – PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June.
- Ingo Bank, Senior Vice President and Chief Financial Officer, will present at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, June 7, 2016 at 4:00 p.m. PDT.
- Josef von Rickenbach, Chairman and Chief Executive Officer, will present at the Jefferies Healthcare Conference in New York City on Wednesday, June 8, 2016, at 1:30 p.m. EDT.
A live webcast of the presentation will be available through the “Investors” section of PAREXEL’s website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website for 90 days after the presentation.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 82 locations in 51 countries around the world, and had approximately 18,450 employees in the third quarter. For more information about PAREXEL International, visit www.PAREXEL.com.
# # #
Ronald Aldridge, Senior Director of Investor Relations